Sodium Carbonate → HCID 117876256, compound
Reaction equation
Br[C:2]1[C:11]([F:12])=[CH:10][C:9]2[N:8]=[CH:7][C:6]3[N:13]=[C:14]([CH3:30])[N:15]([CH:16]4[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:28])([CH3:27])[CH3:26])=[O:23])[CH2:18][CH:17]4[F:29])[C:5]=3[C:4]=2[CH:3]=1.[Cl:31][C:32]1[CH:33]=[C:34]([CH:42]=[CH:43][C:44]=1B1OC(C)(C)C(C)(C)O1)[O:35][C:36]1[N:41]=[CH:40][CH:39]=[CH:38][N:37]=1.C([O-])([O-])=O.[Na+].[Na+].CO.C(Cl)Cl>C1(C)C=CC=CC=1.C(O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[Cl:31][C:32]1[CH:33]=[C:34]([O:35][C:36]2[N:37]=[CH:38][CH:39]=[CH:40][N:41]=2)[CH:42]=[CH:43][C:44]=1[C:2]1[C:11]([F:12])=[CH:10][C:9]2[N:8]=[CH:7][C:6]3[N:13]=[C:14]([CH3:30])[N:15]([C@H:16]4[CH2:21][CH2:20][N:19]([C:22]([O:24][C:25]([CH3:27])([CH3:28])[CH3:26])=[O:23])[CH2:18][C@@H:17]4[F:29])[C:5]=3[C:4]=2[CH:3]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Conditions
- Temperature
- 90 °C
Procedure
tert-Butyl 4-(8-bromo-7-fluoro-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)-3-fluoropiperidine-1-carboxylate (9 g, 0.018 mol) was dissolved in toluene:ethanol (8:2, 50 ml) in a 250 ml seal tube and degasified the reaction mixture with argon gas for 15 minutes. Tetrakis (2.1 g, 0.0018 mol) was added and degasified the reaction mixture with argon gas for 5 minutes, 2-(3-chloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenoxy)pyrimidine (8 g, 0.024 .mol), followed by 2M Na2CO3(5 ml) was added and finally degasified the reaction mixture with argon gas for 10 minutes. The resulting reaction mixture was heated 5 h at 90° C. The reaction was monitored by TLC (5% MeOH/DCM), after completion of reaction by TLC the reaction mixture poured into ice water and extracted with EtOAc (3×100 mL). The combined organic layers were washed water, brine solution, dried over sodium sulphate and evaporated under vacuum. The residue was purified by column chromatography on silica gel (0-3% MeOH/DCM) to afford (3S,4S)-tert-butyl 4-(8-(2-chloro-4-(pyrimidin-2-yloxy)phenyl)-7-fluoro-2-methyl-1H-imidazo[4,5-c]quinolin-1-yl)-3-fluoropiperidine-1-carboxylate, 4 (10.2 g, 95% yield). 1HNMR (CDCl3, 400 MHz): δ 9.28 (d, 1H), 8.68-8.60 (m, 2H), 8.34-8.31 (d, 0.8H), 8.17 (d, 0.2H), 8.09-8.02 (m, 1H), 7.58-7.44 (m, 2H), 7.30 (dd, 1H), 7.16-7.10 (m, 1H), 5.62-5.04 (m, 1H), 4.89-4.25 (m, 3H), 3.10-2.75 (m, 5H), 2.40-2.20 (m, 2H), 1.51 (s, 9H); LCMS: 98.99%, m/z=607.45 (M+1); HPLC: 96.89%, rt: 4.32 min.
Workup
- customseal tube
- customfor 15 minutes
- customfor 5 minutes
- additionwas added
- customfor 10 minutes
- customThe resulting reaction mixture
- customafter completion of reaction by TLC the reaction mixture
- extractionextracted with EtOAc (3×100 mL)
- washThe combined organic layers were washed water, brine solution
- dry with materialdried over sodium sulphate
- customevaporated under vacuum
- customThe residue was purified by column chromatography on silica gel (0-3% MeOH/DCM)
Sources & evidence
- ORD record
- ord-2ab51fbe1798411db44be7e25f098dd6
- Source dataset
- uspto-grants-2016_01
- Patent number
- US09227969B2
Reaction notes
Loading…